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Abstract Aromatic-ring stacking is pronounced among
the noncovalent interactions occurring in biosystems and
therefore some pertinent features regarding nucleobase
residues are summarized. Self-stacking decreases in the
series adenine [ guanine [ hypoxanthine [ cytosine *
uracil. This contrasts with the stability of binary
(phen)(N) adducts formed by 1,10-phenanthroline (phen)
and a nucleobase residue (N), which is largely independent
of the type of purine residue involved, including (N1)H-
deprotonated guanine. Furthermore, the association con-
stant for (phen)(A)0/4- is rather independent of the type
and charge of the adenine derivative (A) considered, be it
adenosine or one of its nucleotides, including adenosine 50-
triphosphate (ATP4-). The same holds for the corre-
sponding adducts of 2,20-bipyridine (bpy), although owing
to the smaller size of the aromatic-ring system of bpy, the
(bpy)(A)0/4- adducts are less stable; the same applies
correspondingly to the adducts formed with pyrimidines. In
accord herewith, [M(bpy)](adenosine)2? adducts (M2? is
Co2?, Ni2?, or Cu2?) show the same stability as the
(bpy)(A)0/4- ones. The formation of an ionic bridge
between –NH3
? and –PO3
2-, as provided by tryptophan
[H(Trp)±] and adenosine 50-monophosphate (AMP2-),
facilitates recognition and stabilizes the indole–purine
stack in [H(Trp)](AMP)2-. Such indole–purine stacks also
occur in nature. Similarly, the formation of a metal ion
bridge as occurs, e.g., between Cu2? coordinated to phen
and the phosphonate group of 9-[2-(phosphonometh-
oxy)ethyl]adenine (PMEA2-) dramatically favors the
intramolecular stack in Cu(phen)(PMEA). The conse-
quences of such interactions for biosystems are discussed,
especially emphasizing that the energies involved in such
isomeric equilibria are small, allowing Nature to shift such
equilibria easily.
Keywords Aromatic-ring stacking  Binary stacking
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1 Introduction
Noncovalent interactions play important roles in modern
chemical research [1], including biosystems. Among these
interactions aromatic-ring stacking is especially prominent
next to hydrogen bonding and hydrophobic and ionic
interactions [2–4]. Indeed, such p stacks are crucial for the
three-dimensional structures of DNA [2, 5, 6] and RNA [7–
9], e.g., in tetraloops and more complicated motifs [10, 11],
as well as for ligand recognition [12].
Of course, p–p stacking also occurs in proteins [13],
e.g., between the indole side chain of tryptophan and the
imidazole residue of histidine [14]. Moreover, stacking
interactions are important for charge transfer in proteins
[15–17] and also in the double helix of DNA [18–20].
Furthermore, stacking and hydrophobic interactions are of
relevance for the formation of protein–nucleic acid adducts
[21–23].
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It appears that the intensity of the various stacks within
DNA affects the charge transport [24, 25]. Indeed, the self-
stacking tendency of the various nucleobase residues
decreases in the order adenine [ guanine [ hypoxan-
thine [ cytosine * uracil [26–29]; the value for thymine
is expected to be at the lower end. In this context we
mention the recent proposal that purine–purine base pairs,
which are capable of greater stacking interactions (com-
pared with pyrimidines), played an important role in a pre-
RNA world [30].
In this review, devoted to the stacking properties of
purine and pyrimidine residues, we will concentrate mainly
on those of the adenine and cytosine residues by pointing
out some new insights. Since self-association occurs for all
aromatic-ring systems in various degrees, here only results
will be considered where this self-association has been
taken into account for both aromatic moieties involved in a
stack.
2 Some comments on self-associations
There are various ways to describe and to quantify self-
association properties [31]. We will concentrate here on the
isodesmic model of indefinite noncooperative self-associ-
ation as defined by equilibrium 1a and Eq. 1b [26, 32, 33]:
ðNÞn þ N ðNÞnþ1 ð1aÞ
Kself ¼ ½ðN)nþ1
ð½ðNÞn½NÞ ð1bÞ
This means the monomeric species N forms a dimer
with a second monomeric species N, then the dimer plus a
further monomeric species N gives rise to a trimer, etc.; the
important point is that all equilibrium constants for the
various steps are identical.
Figure 1 (top) shows the structures of adenosine (Ado)
and cytidine together with the corresponding constants for
self-association [26]. As one would expect, the self-asso-
ciation of the purine derivative is more pronounced (by a
factor of approximately 10) than that of the pyrimidine
derivative. This is in accord with the general expectation
that self-association is the more pronounced the larger the
aromatic system is, and it agrees further with the already
known order given in Sect. 1 for nucleobase residues.
These equilibrium constants as well as the other ones given
in Fig. 1 were determined by 1H-NMR shift measurements
[26, 34, 35].
The effect of the size of the aromatic moiety on the
extent of self-association is also nicely borne out from the
data shown in the middle part of Fig. 1 [34]. The hetero-
aromatic amines (Arm) 1,10-phenanthroline (phen) and
2,20-bipyridine (bpy) are often used in coordination
chemistry [36, 37], but also as ‘‘indicator’’ compounds
regarding stack formation, and therefore relatively much
information about these two compounds exists (e.g. [4,
38]). We will take advantage of this fact by considering
them as well in this review.
As one would expect, coordination of a divalent metal
ion such as Zn2? to phen or bpy will strongly reduce the
self-association tendency owing to the repulsion of the
positive charges of the metal ions which lay within the
plane defined by the aromatic moieties. This is nicely borne
out from a comparison of the data given in the middle and
lower parts of Fig. 1 [35]. Although the self-association is
reduced by a factor of approximately 25–30 because of
Fig. 1 Chemical structures of the nucleosides adenosine (Ado) and
cytidine (Cyd) as well as those of the heteroaromatic nitrogen bases
(Arm) 1,10-phenanthroline (phen) and 2,20-bipyridine (bpy), and their
Zn2? complexes, Zn(phen)2? and Zn(bpy)2?. Below the structures are
given the corresponding self-association constants, Kself, as defined by
Eq. 1b, together with their error limits (2r); these constants were
measured in D2O as solvent at 27 C by 1H-NMR shift experiments
(I = 0.1 M, NaNO3, except for the Zn
2? complexes, where I varied).
The constants for the nucleosides, the heteroaromatic amines, and
their complexes are taken from [26], [34], and [35], respectively
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repulsion, it is not zero and it is still seen that the self-
association tendency of Zn(bpy)2? is only approximately
one quarter of that of Zn(phen)2?. This factor also corre-
sponds with that observed for the self-association of bpy
and phen.
To conclude, Fig. 1 confirms that the larger the aromatic
moiety is that one considers, the larger is the self-association
tendency. The presence of a positive charge (as well as of a
negative one [28, 38–40]) reduces the self-association ten-
dency considerably, but it does not completely disappear.
3 Some comments on the stability of binary stacks
The stability of a binary stack formed, e.g., between a
heteroaromatic amine (Arm) and a nucleobase residue (N),
can be defined according to equilibrium 2a and Eq. 2b:
Arm þ N ðArmÞðNÞ ð2aÞ
K
ðNÞ
ðArmÞðNÞ ¼ ½ðArmÞðNÞ=ð½Arm][N]Þ ð2bÞ
As said before, constants to be determined according to
Eq. 2b need to be measured under conditions where either
self-association is negligible or it needs to be taken into
account [34, 38].
The stability constants for several binary stacks as
defined by Eq. 2b are compiled in Table 1 [34, 38, 41, 42].
These data allow many conclusions; the most important
ones follow:
1. Entry 1 refers to (phen)(A)0/4- (where A is Ado or one
of its nucleotides), for which K
ðAÞ
ðphenÞðAÞ = 37.4 ±
2.9 M-1 (2r) is listed. This means the association
constant between the aromatic rings of phen and those
of the adenine moiety is independent of the residue, be
it simply a ribosyl group or a ribosyl 50-triphosphate.
In other words, the stability of the binary stack formed
with Ado is within the error limits identical with that
of the binary stack formed by adenosine 50-triphos-
phate (ATP4-). Of course, the same stability is within
the error limits also observed for the (phen)(AMP)2-
stacks [41]. Hence, one may conclude that the stability
of a binary stack is independent of the charge that one
of the partners carries as long as the other partner is
neutral and no steric effects are introduced. This is in
accord with the other entries listed in Table 1.
2. For (bpy)(A)0/4- (entry 2) the same comments hold as
given above for (phen)(A)0/4-. However, the stability of
the binary (bpy)(A)0/4- stacks is smaller by a factor of
about 1/2 than the stability observed for (phen)(A)0/4-.
This agrees with the expectation because the overlap of a
purine system with that of bpy will be smaller than the
overlap of a purine system with phen.
3. Replacement of adenine by either an uracil or a
cytosine moiety leads to a significant further reduction
in stability of the binary stacks as is seen from a
comparison of the values in entries 3 and 4 with the
value in entry 2. The reduction by a factor of about 1/7
is very pronounced.
4. In accord with the effect of charges mentioned above,
[M(bpy)](Ado)2? (entry 5), where M2? is Co2?, Ni2?,
or Cu2?, shows the same stability within the error
limits as (bpy)(A)0/4- (entry 2). This means the
twofold positive charge at bpy due to M2? coordina-
tion has no significant effect on the stability of the
stack formed with Ado. Of course, with adenosine 50-
monophosphate (AMP2-) this is different [41] because
then the two aromatic partners involved in the
formation of the stack can be linked by a coordinated
metal ion (see Sect. 5).
4 The favorable effect of an ionic bridge
on the formation of a binary stack
Figure 2 shows the structures of the zwitterionic form of
tryptophan [H(Trp±)], an amino acid residue often present
in proteins and involved in stack formation [13, 14],
together with the adenine nucleotide AMP2- [43–45].
Entry 1 in Table 2 gives the stability of the stack formed
between the indole residue of Trp- and the purine-ring
system of AMP2-, i.e., for the species (Trp)(AMP)3- [46].
Both partners carry a negative charge at the carboxylate
group and the phosphate residue, respectively; however,
Table 1 Stability constants of several (Arm)(N) stacks (Eq. 2b),
where Arm is a heteroaromatic amine and N is a nucleoside deriva-
tive, in aqueous solution as determined by 1H-NMR shift (entries 1–
4) or UV spectrophotometric (entry 5) measurements at a temperature
close to 25 C and I close to 0.1 M (NaNO3)
Entry (Arm)(N) K
ðNÞ
ðArmÞðNÞ
(M-1)
log K
ðNÞ
ðArmÞðNÞ
References
1 (phen)(A)0/4- 37.4 ± 2.9a 1.57 ± 0.04a –
2 (bpy)(A)0/4- 18 ± 8 1.26 ± 0.19 [38]
3 (bpy)(U)0/4- *2.3 *0.36 [38]
4 (bpy)(C)0/4- *2.5b *0.4b –
5 [M(bpy)](Ado)2? 18.3 ± 4.5 1.26 ± 0.11 [38, 42]
The NMR measurements were made in D2O; for details see [38]. The
error limits are twice the standard error of the mean value (2r)
A = adenosine (Ado) or residue; bpy = 2,20-bipyridine; C = cytidine or
residue; M2? = Co2?, Ni2?, or Cu2?; phen = 1,10-phenanthrolin; U =
uridine or residue
a Average of the values listed in Table 4 in [38] for the adducts
(phen)(Ado) [38], (phen)(20-AMP)2- [41], (phen)(30-AMP)2- [41],
(phen)(50-AMP)2- [41], and (phen)(ATP)4- [34]
b Estimate
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because both charged residues are relatively far away from
the aromatic moieties, the charged groups can be orientated
such that they are relatively distant from each other and
therefore the repulsion is relatively small. However, if one
measures the association between AMP2- and tryptophan
under conditions (pD = 8.4) where the latter is present in
its zwitterionic form H(Trp)±, the amino group carrying a
proton (entry 2), an interaction between the –NH3
? and the
–PO3
2- groups results (Fig. 2) [46]. This interaction leads
to an ionic bridge (or hydrogen bond) between the indole
and adenine residues forming the stack. This bridge
enhances the stability of the adduct (entry 2) by a factor of
approximately 3 and thus facilitates the recognition
between the indole and adenine residues.
Entry 3 in Table 2 gives the stability of the
[H(Trp)](ATP)4- adduct [47]. In this case an ionic bridge
can be formed as well, although it is not clear, of course,
which phosphate unit is actually involved; possibly there
are equilibria. However, within the error limits, the sta-
bilities of [H(Trp)](ATP)4- and [H(Trp)](AMP)2- are
identical.
Entries 4 and 5 in Table 2 mirror the results discussed
for the adenine nucleotides, except that the stabilities of the
CMP2- adducts are, as expected, much smaller.
Evidently in the H(Trp)± adducts in solution not only a
stack with an ionic bridge is present but there are also two
‘‘open’’ isomers: one with only an ionic interaction (ii) and
one where only a stack (st) without the ionic bridge occurs
[46]. The stability of the latter for the AMP2- adduct in a
first approximation is given by entry 1 in Table 2
(2.24 ± 0.58 M-1; 2r), whereas the stability for the adduct
with the ionic interaction has been estimated as being close
to Kii = 1.0 ± 0.5 M
-1 (average of the values given in
[46]). These values can now be used to estimate the per-
centages of the various adducts formed. Clearly, there are
three different isomers in equilibrium with each other,
which are, if we abbreviate H(Trp)± as HT± and AMP2-
as A2-, the two ‘‘open’’ species (HT)(A)st2- and
(HT)(A)ii2-, plus the ‘‘closed’’ one (HT)(A)cl2-, in which
both the ionic and the stacking interactions occur. The
measured (exp) stability constant, which quantifies the total
(tot) amount of adducts formed, is defined by Eqs. 3a and
3b and it is composed of the (micro) stability constants
given in Eq. 3c:
K
ðAÞ
ðHTÞðAÞexp ¼
½ðH  TÞðAÞ2tot 
½ðH  TÞ½ðAÞ2 ð3aÞ
K
ðAÞ
ðHTÞðAÞexp ¼
½ðH  TÞðAÞ2st  þ ½ðH  TÞðAÞ2ii  þ ½ðH  TÞðAÞ2cl 
½ðH  TÞ½ðAÞ2
ð3bÞ
K
ðAÞ
ðHTÞðAÞexp¼ K
ðAÞ
ðHTÞðAÞst þ K
ðAÞ
ðHTÞðAÞii þ K
ðAÞ
ðHTÞðAÞcl ð3cÞ
Insertion of the (micro) constants mentioned above (see
also Table 2) into Eq. 3c leads to Eq. 4, from which the
result in Eq. 5 follows:
ð6:83  1:62Þ ¼ ð2:24  0:58Þ þ ð1:0  0:5Þ þ KðAÞðHTÞðAÞcl
ð4Þ
K
ðAÞ
ðHTÞðAÞcl ¼ 3:59  1:79 ð5Þ
Now the right-hand parts of Eqs. 3a and 3b can be set
equal, leading to Eqs. 6a and 6b and the molar fractions
given in Eq. 7:
Fig. 2 Chemical structures of the zwitterionic form of tryptophan
[H(Trp)±] and adenosine 50-monophosphate (50-AMP2-) (also abbre-
viated simply as AMP2-). The nucleotide is shown in its dominating
anti conformation [6, 43–45]
Table 2 Stability constants (analogous to Eq. 2b) of the adducts
formed between Trp- or H(Trp)± (=T) and AMP2-, ATP4-, or
CMP2- (=N) as determined by 1H-NMR shift measurements in D2O
at 27 C and I = 0.1 M (KNO3 or NaNO3)
Entry (T)(N) K
ðAÞ
ðTÞðAÞ (M
-1) References
1 (Trp)(AMP)3- 2.24 ± 0.58 [46]
2 [H(Trp)](AMP)2- 6.83 ± 1.62 [46]
3 [H(Trp)](ATP)4- 6.2 ± 1.2 [47]
4 (Trp)(CMP)3- 0.14 ± 0.05 [46]
5 [H(Trp)](CMP)2- 0.77 ± 0.42 [46]
The error limits for entries 1–3 are 2r; those for entries 4 and 5 are
estimates
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HTð Þ Að Þ2tot
h i
¼ HTð Þ Að Þ2st
h i
þ HTð Þ Að Þ2ii
h i
þ HTð Þ Að Þ2cl
h i
ð6aÞ
ð6:83 1:62Þ¼ð2:24 0:58Þþð1:0 0:5Þþð3:59 1:79Þ
ð6bÞ
1 ¼ ð0:328  0:114Þþ ð0:146  0:081Þþ ð0:526  0:291Þ
ð7Þ
Hence, the formation degrees (error 2r) of the three
isomers (HT)(A)st2-, (HT)(A)ii2-, and (HT)(A)cl2- follow as
given in Eq. 8:
100 % ¼ ð33  11Þ % þ ð15  8Þ % þ ð53  29Þ %
ð8Þ
Not surprisingly, the open isomer with an ionic bridge
(hydrogen bond), (HT)(A)ii2-, is a minority species (about
15 %), whereas the closed isomer, (HT)(A)cl2-, involving both
types of interactions is the dominating one (about 55 %).
Moreover, the sum of the species containing an aromatic-ring
stack is the overwhelming adduct (nearly 90 %, i.e.,
53 ? 33 %). Naturally, with the results presented at hand,
one may also calculate the intramolecular equilibrium constants
(KI) for the transformation of one isomer into another one. The
interdependencies between these equilibria are summarized in
the equilibrium scheme shown in Fig. 3. The corresponding
dimensionless equilibrium constants are approximately
KI/st = [(HT)(A)cl2-]/[(HT)(A)st2-] = 0.526/0.328 & 1.60,
KI/ii = [(HT)(A)cl2-]/[(HT)(A)ii2-] = 0.526/0.146 & 3.60, and
KI/ii,st = [(HT)(A)st2-]/[(HT)(A)ii2-] = 0.328/0.146 & 2.25.
With the above information in mind, it is no surprise to
find that protein–nucleic acid interactions in biosystems
may occur on the basis of Trp/indole–AMP/adenine stacks.
Figure 4 presents such an example [48, 49]. It is of addi-
tional interest to see in Fig. 4 that the RNA hairpin is
further stabilized by stacks between four consecutive
(somewhat twisted) adenine residues; indeed, among all
nucleobases, self-association is most pronounced for the
adenine moiety (see Sect. 1). Such adenine–adenine stacks
are also of relevance for the oxidation of oligonucleotides
[50]. Combinations of p–p interactions also occur in recog-
nition reactions, e.g., between the tyrosine or phenylalanine
residues of a protein and the cytosine or adenine moieties
of an RNA, respectively [51].
Fig. 3 Summary of the various adducts formed between H(Trp)±
(=HT±) and AMP2- (=A2-) and their corresponding equilibrium
constants. For the definition and properties of the various species, see
the text in Sect. 4
Fig. 4 Stack formation between an indole residue (red) of a protein-
tryptophan and an adenine–RNA moiety (blue) in the N36 peptide-
box B RNA complex of bacteriophage Lambda [48]. The figure was
prepared with MOLMOL [49] using Protein Data Bank entry 1QFQ
Fig. 5 Stack formation between an indole residue (red) of a protein-
tryptophan and guanine–RNA moieties (blue) in the SR-like protein
ZRANB2 and the RNA in its single-stranded RNA-binding domain
[52]. The figure was prepared with MOLMOL [49] using the Protein
Data Bank entry 3G9Y
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The self-association of the guanine residue (KGuoself ¼
8  3 M1; Eq. 1b [28]) is only about half as pronounced
as that of the adenine residue (KAdoself ¼ 15  3 M1; see
Sect. 1 [26–28]), yet the stability of the binary nucleoside
stacks involving phen is within the error limits identical;
the stability constants according to Eq. 2b [38] are:
KAdoðphenÞðAdoÞ ¼ 42  9:5 M1for (phen)(Ado), 42 ± 5 M-1
for (phen)(Guo), and (42 ± 5.5 M-1) for (phen)(Guo - H)-.
Hence, it is no surprise to find an intercalated indole residue
between two guanine moieties in a zinc finger–RNA adduct
(Fig. 5) [52].
Naturally, in the above examples (Figs. 4, 5) stack for-
mation is indirectly facilitated by a suitable organization of
the backbones of the macromolecules.
5 A metal ion bridge favors the extent of stacking
interactions involving nucleotide analogues
5.1 General considerations on the properties of acyclic
nucleoside phosphonates
Provided the two aromatic moieties involved in the for-
mation of a stack also have groups that allow the coordi-
nation of a metal ion in a suitable manner, then a bridge
between the two partners involved in the stack may be
formed. Because relatively comprehensive information
exists on phosphonomethoxyethyl derivatives, which con-
tain a nucleobase residue, we have selected 1-[2-(phos-
phonomethoxy)ethyl]cytosine (PMEC) and 9-[2-
(phosphonomethoxy)ethyl]adenine (PMEA) for our com-
parisons. Both compounds can be considered as acyclic
nucleoside phosphonates; they are of interest owing to their
potential antiviral activity and therefore they are widely
studied [53–55]. Figure 6 shows the structures of the dia-
nions of PMEC and PMEA, which, aside from possible
other sites, offer a phosphonate group for metal ion bind-
ing. The ‘‘aliphatic’’ chains of the two nucleobases are
mimicked by (ethoxymethyl)phosphonate (PME2-) depic-
ted at the top of Fig. 6.
The acyclic nucleoside phosphonates PMEC2- and
PMEA2- are of course able to undergo stack formation
with the heteroaromatic amines shown in Fig. 1, allowing
in addition the formation of a metal ion bridge by coordi-
nation of a metal ion to the pyridine-type N sites of het-
eroaromatic amines and the phosphonate groups of the
PME2- derivatives. As examples, the tentative and sim-
plified structures of Cu(phen)(PMEC) and Cu(phen)-
(PMEA) containing an intramolecular stack are shown in
the lower part of Fig. 6.
The situation is somewhat complicated by the formation
of a five-membered chelate formed by the phosphonate-
coordinated metal ion with the ether oxygen of the aliphatic
chain [54, 56, 57]. This gives rise to the intramolecular
equilibrium 9, the position of which is quantified by the
dimensionless equilibrium constant KI (Eq. 10):
KI=O ¼ ½MðPEÞcl=O
.
½M(PE)op ð10Þ
(PE2- is PME2-, PMEC2-, or PMEA2-).
Of course, any metal ion interaction next to the inter-
action with the phosphonate group must lead to enhanced
complex stability [58, 59]. This is nicely seen, e.g., in
Fig. 7, where the straight line as defined by the log
K
CuðphenÞ
CuðphenÞðRPO3Þ versus pK
H
HðRPO3Þ plot represents the sta-
bility of Cu(phen)(R–PO3) species. This straight line was
determined by using for R–PO3
2- ligands such as ribose
5-phosphate, methylphosphonate, and ethylphosphonate,
Fig. 6 Chemical structures of the dianions of (phosphonomethoxy)eth-
ane [PME2- = (ethoxymethyl)phosphonate], 1-[2-(phosphonometh-
oxy)ethyl]cytosine (PMEC2-), and 9-[2-(phosphonomethoxy)ethyl]-
adenine (PMEA2-); these three compounds are abbreviated as PE2-.
Also shown are tentative and simplified structures of Cu(phen)(PMEC)
and Cu(phen)(PMEA) species with an intramolecular stack. The
orientation of the aromatic rings may vary among the stacked species;
such a stacked complex in solution should not be considered as being
rigid; hence, equilibria are expected between such stacks
   (9)
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that is, ligands which cannot undergo any metal ion
interaction aside from interaction with the PO3
2- group
[60–62].
In Fig. 7 one sees that the Cu(phen)(PME) complex is
more stable than expected according to the basicity of the
phosphonate group of PME2- [63]. Hence, equilibrium 9
definitely exists. However, it is further evident from Fig. 7
that the stabilities of the Cu(phen)(PMEC) and
Cu(phen)(PMEA) complexes are even higher than the
stability of Cu(phen)(PME) [61, 62, 64]. This must mean
that in these two complexes containing an acyclic nucle-
oside phosphonate derivative, next to the five-membered
chelate seen in equilibrium 9, a further interaction must
occur, namely, stack formation as shown in the lower part
of Fig. 6. This stack formation (also proven by other
methods [62, 64]) is indicated in the intramolecular equi-
librium 11, the position of which is defined by KI/st
according to Eq. 12:
KI=st ¼ [M(Arm)(PE)st=½M(Arm)(PE)op ð12Þ
The situation described in the preceding paragraph can
be summarized in the equilibrium scheme 13 from which it
follows that Cu(Arm)(PE)op species can form either the
five-membered chelate designated as Cu(Arm)(PE)cl/O or
the stacked species designated as Cu(Arm)(PE)st. The
simultaneous formation of the five-membered chelate
within the equatorial Cu2? sites and the formation of a
stack within the same ternary complex is not possible as
concluded previously [61, 65], but stacks with somewhat
different orientations of the aromatic rings towards each
other may exist. As there is at present no way to distinguish
in solution the various conformers/isomers from each
other, all stacked ternary species are treated together and
designated as Cu(Arm)(PE)st, as already done above. Stack
formation has not only been established in the indirect
manner via stability considerations, as discussed here
(Fig. 7), but also directly by spectroscopic methods (for
references, see [64]).
5.2 Evaluation of the equilibria involving three
isomeric complexes
From the discussion in Sect. 5.1 it follows that there are
three isomeric complexes in equilibrium with each other,
and this means that for the experimentally measured
overall stability constant the following equations hold [57,
61, 65, 66]:
K
CuðArmÞ
CuðArmÞðPEÞ ¼
½CuðArmÞðPEÞ
½CuðArmÞ2þ½PE2 ð14aÞ
Fig. 7 Evidence for an enhanced stability of ternary Cu(phen)(PE)
complexes, where PE2- is PME2- (diamond), PMEC2- (triangle), or
PMEA2- (circle), based on the relationship between log
K
CuðphenÞ
CuðphenÞðRPO3Þ or log K
CuðphenÞ
CuðphenÞðPEÞ and pK
H
HðRPO3Þ or pK
H
HðPEÞ in
aqueous solution at I = 0.1 M (NaNO3) and 25 C. The data plotted
are from [60–62]. The reference line represents the log
K
CuðphenÞ
CuðphenÞðRPO3Þ versus pK
H
HðRPO3Þ relationship for the ternary
Cu(phen)(R–PO3) complexes (Eq. 18); R–PO3
2- symbolizes phos-
phonates or phosphate monoesters in which the group R is unable to
undergo any kind of hydrophobic, stacking, or other type of
interaction, i.e., ligands such as D-ribose 5-monophosphate, metha-
nephosphonate, or ethanephosphonate [61, 63]. Hence, the straight
line represents the situation for ternary complexes without an
intramolecular ligand–ligand interaction. The vertical broken lines
emphasize the stability differences from the reference line; they equal
log DCu/Arm/PE as defined in Eqs. 16a and 16b
   (13) 
J Biol Inorg Chem (2014) 19:691–703 697
123
K
CuðArmÞ
CuðArmÞðPEÞ ¼
½CuðArmÞðPEÞopþ ½CuðArmÞðPEÞcl=Oþ ½CuðArmÞðPEÞst
½CuðArmÞ2þ½PE2
ð14bÞ
K
CuðArmÞ
CuðArmÞðPEÞ¼KCuðArmÞCuðArmÞðPEÞopð1 þ KI=O þ KI=stÞ ð14cÞ
Of course, the stability of the open species is defined by
Eq. 15 as follows from the equilibrium scheme 13.
K
CuðArmÞ
CuðArmÞðPEÞop ¼
½CuðArmÞðPEÞop
½CuðArmÞ2þ½PE2 ð15Þ
Furthermore from Fig. 7 it follows that the stability
enhancement log DCu/Arm/PE is defined by Eqs. 16a and 16b:
log DCu=Arm=PE ¼ log KCuðArmÞCuðArmÞðPEÞ log KCuðArmÞCuðArmÞðPEÞop
ð16aÞ
log DCu=Arm=PE ¼ log KCuðArmÞCuðArmÞðPEÞexptl log K
CuðArmÞ
CuðArmÞðPEÞcalcd
ð16bÞ
The two terms which appear on the right hand side in
Eqs. 16a and 16b are analogous. The first one is the mea-
sured constant and the second one, which represents the
stability of the open isomer (Eq. 15), can be calculated with
the pKHHðRPO3Þ value of H(PE)
- and the straight line Eqs. 17
and 18 for the Cu(bpy)(R–PO3) and Cu(phen)(R–PO3)
systems, respectively [59, 61]:
log K
CuðbpyÞ
CuðbpyÞðRPO3Þ ¼ 0:465  pKHHðRPO3Þ þ 0:009 ð17Þ
log K
CuðphenÞ
CuðphenÞðRPO3Þ ¼ 0:465  pKHHðRPO3Þ þ 0:018 ð18Þ
The total stability enhancement according to Eqs. 16a and
16b encompasses, of course, both the formation of the stack
(equilibrium 11) and the five-membered chelate involving the
ether oxygen (equilibrium 9). Therefore, an overall or total
intramolecular equilibrium constant, i.e., KI/tot, can be defined
according to Eqs. 19a, 19b, 19c, and 19d:
KI=tot ¼
K
CuðArmÞ
CuðArmÞðPEÞ
K
CuðArmÞ
CuðArmÞðPEÞop
 1 ¼ ½CuðArmÞðPEÞint=tot½CuðArmÞðPEÞop
ð19aÞ
KI=tot ¼
½CuðArmÞðPEÞcl=O þ ½CuðArmÞðPEÞst
½Cu(Arm)(PE)op
ð19bÞ
KI=tot ¼ KI=O þ KI=st ð19cÞ
KI=tot ¼ 10logDCu=Arm=PE1 ð19dÞ
The values for the equilibrium constants which appear
on the right-hand side of Eqs. 16a and 16b are found in the
literature [61–63]. For the present, it is only important to
note that log DCu/Arm/PE corresponds to the vertical
distances seen in Fig. 7 between the measured data point of
a given complex and the intercept with the straight line
representing the stability of the open complex. These log
DCu/Arm/PE values are listed in the second column in
Table 3. Application of Eqs. 19a, 19b, 19c, and 19d to these
data provides the values for KI/tot which are given in column 3.
Of course, once KI/tot is known, one may calculate according to
Eq. 20 the total percentage of all species with an intramole-
cular interaction (Table 3, column 4):
% Cu(Arm)(PE)int=tot ¼ 100  KI=tot=ð1 þ KI=totÞ ð20Þ
At this point two important conclusions may be drawn
from the results assembled in Table 3: (1) The first two
entries which refer to the Cu(Arm)(PME) complexes
describe the situation according to equilibrium 9, i.e.,
KI/tot = KI/O and % Cu(Arm)(PME)int/tot = % Cu(Arm)-
(PME)cl/O, and of course, the same KI/O values are expected
to hold for the other entries in rows 3–6 in Table 3. (2)
Because column 4 in Table 3 provides the total formation
degree of all the species which contain an intramolecular
interaction, it follows that % Cu(Arm)(PE)op = 100 % –
% Cu(Arm)(PE)int/tot.
On the basis of the above conclusions, Table 4 contains
in the second column the calculated values for %
Cu(Arm)(PE)op. Because KI/tot is known as is KI/O, from
Eq. 19c KI/st can be calculated for the Cu(Arm)-
(PMEC) and Cu(Arm)(PMEA) systems. These intramole-
cular equilibrium constants, KI/st, are listed in column 4 in
Table 4. Combination of % Cu(Arm)(PE)op with KI/O and KI/st
(see Eqs. 10, 12) provides the results listed in columns 5 and 6 in
Table 4. That is, for the Cu(Arm)(PMEC)and Cu(Arm)(PMEA)
systems, the percentages of all three isomers which occur in the
equilibrium scheme 13 are known.
5.3 Some conclusions about the properties
of the Cu(Arm)(PE) complexes
Several conclusions are possible from the results assembled
in Table 4:
1. Formation of the ternary complexes with an intramole-
cular stack occurs on account of the isomers containing
the five-membered chelate involving the ether oxygen.
2. The percentage of Cu(Arm)(PMEC)st does not signif-
icantly differ for the complexes containing either bpy
or phen; it is close to 65 %. This is understandable
because the overlap of a pyrimidine residue with bpy
or phen will not differ much.
3. This is different for the systems containing PMEA.
Here the stability of the intramolecular stack is higher
by a factor of about 2 for the Cu(phen)(PMEA) species
compared with that of Cu(bpy)(PMEA) as follows
from the KI/st values (column 4).
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4. Of course, as expected, the formation degree of the
stacked ternary species containing PMEA2- is much
higher than of those containing PMEC2- (see the
results in columns 4 and 6).
At this point it is interesting to compare the stacking
properties in the ternary Cu(Arm)(L) complexes, where L
represents either an acyclic nucleoside phosphonate or one
of its parents, i.e., a nucleoside 50-monophosphate. The
corresponding structures are shown in Fig. 8 [39, 67–71].
In entries 1 and 2 in Table 5 the relevant data from
Table 4 are repeated. Entries 3 and 4 contain the results for
the Cu(Arm)(NMP) systems as taken from the literature
[41, 72]. Naturally, in these latter instances, no five-membered
chelates according to the equilibrium 9 can be formed, but
intramolecular stacking interactions are possible, of course. It is
now interesting to see that stack formation is less pronounced in
the complexes containing NMP2- = CMP2- or AMP2- than in
those containing PE2- = PMEC2- or PMEA2-.
The latter point is especially clearly seen from the
intramolecular equilibrium constants KI/st, which quantify
the stability of the intramolecular stacks (Table 5, column
Table 3 Stability enhancements, log DCu/Arm/PE (Eqs. 16a, 16b), and formation degrees, % Cu(Arm)(PE)int/tot (Eq. 20), of the sum (tot) of all
species with an intramolecular (int) interaction in several Cu(Arm)(PE) complexes (Eqs. 19a, 19b) as determined in aqueous solution at 25 C
and I = 0.1 M (NaNO3)
Cu(Arm)(PE)a log DCu/Arm/PE KI/tot % Cu(Arm)(PE)int/tot References
Cu(bpy)(PME) 0.59 ± 0.08 2.89 ± 0.68b 74 ± 5b [61, 63]
Cu(phen)(PME) 0.62 ± 0.07 3.17 ± 0.69b 76 ± 4b [61, 63]
Cu(bpy)(PMEC) 1.02 ± 0.09 9.47 ± 2.22 90.45 ± 2.03 [62]
Cu(phen)(PMEC) 1.11 ± 0.08 11.88 ± 2.32 92.24 ± 1.40 [62]
Cu(bpy)(PMEA) 1.48 ± 0.07 29.20 ± 4.87 96.69 ± 0.53 [61]
Cu(phen)(PMEA) 1.74 ± 0.07 53.95 ± 8.86 98.18 ± 0.29 [61]
The data were abstracted from Table 3 in [62]. The error limits are 3r
a For the structures of the PE2- ligands, see Fig. 6
b For the Cu(Arm)(PME) systems, KI/tot = KI/O (Eqs. 10, 19c) holds
Table 4 Formation degrees of the three differently structured Cu(Arm)(PE) isomers as they appear in the equilibrium scheme 13 and as present
in aqueous solution at 25 C and I = 0.1 M (NaNO3)
Cu(Arm)(PE)a % Cu(Arm)(PE)op KI/O KI/st % Cu(Arm)(PE)cl/O % Cu(Arm)(PE)st
Cu(bpy)(PME) 26 ± 5 2.89 ± 0.68 – 74 ± 5 –
Cu(phen)(PME) 24 ± 4 3.17 ± 0.69 – 76 ± 4 –
Cu(bpy)(PMEC) 9.55 ± 2.03 2.89 ± 0.68 6.58 ± 2.32 28 ± 9 62 ± 9
Cu(phen)(PMEC) 7.76 ± 1.40 3.17 ± 0.69 8.71 ± 2.42 25 ± 7 67 ± 7
Cu(bpy)(PMEA) 3.31 ± 0.53 2.89 ± 0.68 26.31 ± 4.92 10 ± 3 87 ± 3
Cu(phen)(PMEA) 1.82 ± 0.29 3.17 ± 0.69 50.78 ± 8.89 6 ± 2 92 ± 2
The data were abstracted from Table 4 in [62] (for details regarding the PME, PMEC, and PMEA systems see also [63], [62], and [61],
respectively). The error limits are 3r
a For the structures of the PE2- ligands, see Fig. 6
Fig. 8 Comparison of the chemical structures of the acyclic nucle-
oside phosphonates PMEC2- and PMEA2- and their corresponding
parent nucleotides cytidine 50-monophosphate (CMP2-) and adenosine
50-monophosphate (AMP2-), respectively. Both nucleotides are shown
in their dominating anti conformation [39, 44, 67–69]. The orientation of
PMEA2- (as shown) in solution [70] (this holds also for the solid state
[71]) resembles the anti conformation of AMP2- [44, 45]
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5). Indeed, the intramolecular stacks in the Cu(Arm)(NMP)
complexes are a factor of about 1/6 less stable than those of
the Cu(Arm)(PE) species. What is the reason for this
somewhat surprising result? A comparison of the structures
shown in Fig. 8 reveals that the ribose ring limits the
flexibility in the Cu(Arm)(NMP) complexes considerably
in comparison with that of the Cu(Arm)(PMEC) and
Cu(Arm)(PMEA) species. This increased flexibility allows
a more strain-free formation of the intramolecular stacks
and thus leads to larger formation degrees.
6 A somewhat speculative application of part
of the results to polymerases
First it is necessary to emphasize that to achieve the
reactive state of a triphosphate chain, two metal ions or at
least two positively charged units including, e.g., –NH3
?,
are needed [73, 74]. We will concentrate here on the
involvement of two divalent metal ions, and this is sum-
marized in Fig. 9 [74–85]. An M(a,b)–M(c) coordination
mode at the triphosphate chain leads to the transfer of a
phosphoryl group (kinases) [74, 75, 86], whereas an M(a)–
M(b,c) binding mode of the two metal ions leads to the
transfer of a nucleotidyl unit as occurs in nucleic acid
polymerases [74, 76, 79, 84]. In both instances a diphos-
phate unit could also be transferred, but this is not of rel-
evance in the present context.
At this point it is important to recall that the antiviral
properties of acyclic nucleoside phosphonates [54] are
achieved by a twofold phosphorylation [87, 88] within the
cell giving rise, e.g., to a PMEApp4- species, which is an
analogue of (d)ATP4-. Evidently, if the PMEApp4- spe-
cies is used as a substrate and incorporated by the poly-
merase into the growing nucleic acid chain [89, 90], the
chain will be terminated because there is no (C30)OH group
allowing the further growth of the nucleic acid chain [91,
92]. This polymerase reaction is shown in a simplified
manner in the lower part of Fig. 9. A comparison between
the properties of M2(PMEApp) and M2(dATP) reveals why
PMEApp4- is a better substrate [54, 82, 83, 93] than
(d)ATP4-: (1) The M(a) coordination is clearly favored
owing to the presence of the ether oxygen, giving rise to a
five-membered chelate (Fig. 9, bottom) [65]. (2) The
electron density at Pa is higher in the phosphonate (and
also the phosphonate basicity) compared with the situation
in phosphate [94, 95], thus facilitating the nucleophilic
attack. These two properties favoring the M(a)–M(b,c)
coordination pattern make PMEApp4- a better substrate
than dATP4- [54, 83].
With the above information in mind, one may ask now
why PMEA is an excellent antiviral drug whereas PMEC is
not. The speculative answer is that PMEApp4- is well
placed in the active-site cavity of the polymerase owing to
its more intense stacking properties compared with
PMECpp4-. Clearly, more work is needed to substantiate
the explanation given.
7 General conclusions
The observation that pyridyl and pyrimidine residues have
a smaller stacking tendency than larger aromatic moieties
such as phen or purine moieties is no surprise. However,
the observation that in a binary stack composed of two
different aromatic systems one may carry either a positive
or a negative charge without a significant alteration of the
stability of the binary stack as long as the other partner is
neutral, that is, does not also carry a charge, is an important
insight and is relevant for biological systems (Sect. 3). For
Table 5 Comparison of the formation degrees of the stacked isomers (Fig. 3, bottom) in the ternary PMEC2- and PMEA2- complexes with
those containing the parent nucleotides CMP2- and AMP2- (NMP2-; see Fig. 8)
Entry Cu(Arm)(PE/NMP) % Cu(Arm)(PE/NMP)op % Cu(Arm)(PE/NMP)cl/O KI/st % Cu(Arm)(PE/NMP)st References
a
1a Cu(Bpy)(PMEC) 9.55 ± 2.03 28 ± 9 6.58 ± 2.32 62 ± 9 [62]
1b Cu(Phen)(PMEC) 7.76 ± 1.40 25 ± 7 8.71 ± 2.42 67 ± 7 [62]
2a Cu(Bpy)(PMEA) 3.31 ± 0.53 10 ± 3 26.31 ± 4.92 87 ± 3 [61]
2b Cu(Phen)(PMEA) 1.82 ± 0.29 6 ± 2 50.78 ± 8.89 92 ± 2 [61]
3a Cu(Bpy)(CMP) 49 ± 9 – 1.04 ± 0.38b 51 ± 9 [72]
3b Cu(Phen)(CMP) 38 ± 6 – 1.63 ± 0.44b 62 ± 6 [72]
4a Cu(Bpy)(AMP) 19 ± 4 – 4.37 ± 1.02b 81 ± 4 [41]
4b Cu(Phen)(AMP) 10 ± 2 – 8.77 ± 1.81b 90 ± 2 [41]
The formation degrees hold for aqueous solutions at 25 C and I = 0.1 M (NaNO3) (error limits 3r)
a See also Table 4 in [62]
b For the Cu(Arm)(NMP) systems, KI/tot = KI/st (Eqs. 12, 19c) holds
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example, a metal ion coordinated at N7 of a purine unit will
not significantly affect the stacking properties of this same
purine residue. It may be emphasized again in this context
that the stabilities of the (phen)(Ado), (phen)(guanosine),
and (phen)(guanosine – HN1)- binary stacks are within the
error limits identical [38] (see also Sect. 4).
That the formation of a bridge between the two partners
of a binary stack will significantly enhance the formation
degree of the stack, and thus facilitate recognition between
the two partners, has become clear from the results
described in Sects. 4 and 5. However, this can be further
emphasized by the following comparison, which refers to
10-3 M solutions of the reactants at a pH of approximately
7 (25 C; I = 0.1 M, NaNO3) [34, 38]: (1) In a mixture of
phen and ATP4- under the given conditions and in aqueous
solution, 3.5 % of the reactants exist as binary (phen)-
(ATP)st
4- stacks. (2) Under exactly the same conditions but
in the presence of Cu2?, 90 % of the reactants are now
present as Cu(phen)(ATP)st
2-. This means the metal ion
bridge promotes the formation of the stack by a factor of
about 25. In mixed solvents, such as water containing 50 %
1,4-dioxane, the promotion of the stack may even become
considerably larger because the organic solvent molecules
solvate hydrophobically the individual stacking partners to
a certain extent, which inhibits the formation of the binary
stacks, whereas this inhibition is considerably less pro-
nounced in the ternary M2? complexes because the M2?
ions attract water molecules, thus inhibiting the hydro-
phobic solvation of the aromatic partners.
At this point it seems helpful to relate the stability
enhancements as observed for intramolecular interactions
in mixed ligand complexes to the free energies involved in
a general manner. The contribution of isomers with an
intramolecular interaction to the change in free energy for
complex formation is given by DG0 = –RT ln DM/A/B [58].
This means for 25 C it holds DG025C = -5.71 9 log DM/A/B
[59]. On this basis, the data assembled in Table 6 were
calculated.
Evidently, a small stability enhancement of log DM/A/B
= 0.1, valid for any mixed ligand M(A)(B) complex con-
taining ligands A and B, means a formation degree of about
20 % for the species with an intramolecular interaction, for
example, a stack. But this corresponds energywise to a
change of only DG0 = -0.57 kJ mol–1. The stability
enhancement of log DM/A/B = 0.3 means that the ‘‘closed’’
species reaches a formation degree of 50 %, but the
Fig. 9 At the top two simplified structures of M2(NTP) complexes
[NTP4- is (20-deoxy)nucleoside 50-triphosphate] are shown: one with
an M(a,b)-M(c) coordination mode (left) relevant for transphosph-
orylations (kinases), and one with an M(a)–M(b,c)-type mode (right)
relevant for the transfer of a nucleotidyl unit as catalyzed by
polymerases. This latter binding mode needs to be enforced by the
enzyme, i.e., both metal ions are anchored [74, 75] to amino acid side
chains, often carboxylate groups of aspartate or glutamate units of the
enzyme [76–81] (CH2–Ns is a nucleoside residue). Of course, one
may think of situations where, e.g., M2? at the b and c groups is
replaced by (a) monovalent metal ion(s) and/or (an) ammonium
residue(s) [73, 74]. The simplified structures in the lower part of the
figure represent the M2(dATP) and M2(PMEApp) intermediates ready
for the attack of a nucleophile (N) and on their way to the transition
state in nucleic acid polymerases [74, 82, 83]. Both metal ions (often
Mg2?) [78, 80, 84] need to be anchored to amino acid side chains of
the enzyme (see above). The nucleophile N (a 30-OH group) may in
addition interact with M2? at Pa and the adenine moiety may be
replaced by any other nucleobase residue. The M(a)–M(b,c)-binding
mode, which is crucial for the polymerase reaction, is favored in
M2(PMEApp) owing to the formation of the five-membered chelate
with the ether oxygen of the aliphatic chain [54, 83]
Table 6 Interrelation between the stability enhancement log DM/A/B
(Eqs. 16a, 16b), the intramolecular equilibrium constant KI (Eqs. 19a,
19b, 19c, 19d), the percentage of the ‘‘closed’’ species with an
intramolecular interaction (II), % M(A)(B)II (Eq. 20), and the change
in free energy DG0 at 25 C
log DM/A/B KI % M(A)(B)II DG
0 (kJ mol–1)
0.05 0.12 10.9 –0.29
0.1 0.26 20.6 –0.57
0.2 0.58 37 –1.14
0.3 1.0 50 –1.71
0.5 2.2 68 –2.86
0.7 4.0 80 –4.00
1.0 9.0 90 –5.71
1.5 30.6 97 –8.57
2.0 99 99 –11.4
3.0 999 99.9 –17.1
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change in free energy of -1.71 kJ mol–1 is still relatively
small. Matters become ‘‘costly’’ only for high forma-
tion degrees. For example, a formation degree of
an intramolecular interaction of 90 % corresponds to a
stability enhancement of 1 log unit and DG0 of
-5.71 kJ mol–1.
Of course, the same interrelations between changes in
free energy and intramolecular chelate formation also hold
for binary complexes of the kind indicated in equilibrium
9. For example, an isolated hydroxyl group, such as in
ethanol, is a poor ligand. However, if connected with a
suitable primary binding site, such as an acetate or pyridine
group as is the case in hydroxyacetate or o-(hydroxy-
methyl)pyridine, respectively, the hydroxyl group transfers
into an excellent ligating site [96], an observation of rele-
vance also for ribozymes/nucleic acids.
To conclude, considering the results described in this
review, it is clear that the correct structure of a substrate for
an enzymatic reaction can be obtained without large
changes in free energy. Or, to say it differently, subtle
conformational changes may have dramatic effects on
‘‘recognition’’ and the reactivity of a system.
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